Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Innovent begins Tyvyt dosing in liver cancer patients

Hepatocellular carcinoma accounts for 70-90% of all liver cancers. Credit: humpath.com via Flickr.



  • Innovent begins Tyvyt dosing in liver cancer patients

Go Top